Skip to main content
SpringerLink
Log in

C

  • Chapter
Therapielexikon Neurologie

  • 1456 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Belcher G, Hübner R, George M, et al. (1997) Candesartan cilexetil: safety and tolerability in healthy volunteers and patients with hypertension. J Hum Hypertens 11(Suppl. 2):85–89

    Google Scholar 

  2. McKelvie RS, Yusuf, Pericak D et al. (1999) Comparison of candesartan, enalapril, and their combination in congestive heart failure. Circulation 100:1056–1064

    PubMed  CAS  Google Scholar 

  3. Riegger GAJ, Bouzo H, Petr P, et al. (1999) Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Circulation 100:2224–2230

    PubMed  CAS  Google Scholar 

Literatur

  1. Killestein J, Hoogervorst ELJ, Reif M et al. (2002) Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 58:1404–7.

    PubMed  CAS  Google Scholar 

Literatur

  1. Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, Nakane Y, Ogawa Y, Avanzini G, Fumarola C, Granata T, Molteni F, Pardi G, Minotti L, Canger R, Dansky L, Oguni M, Lopes-Cendas I, Sherwin A, Andermann F, Seni MH, Okada M, Teranishi T (1999). Congenital malformations due to antiepileptic drugs. Epilepsy Res 33:145–158.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Martini R, Zielasek J, Toyka KV (1998) Inherited demyelinating neuropathies: from Gene to disease. Curr Opin Neurol 11: 545–556.

    PubMed  CAS  Google Scholar 

Literatur

  1. Podoll K et al. (1989) Das Charles-Bonnet-Syndrom. Fortschr Neurol Psychiatr 57:43–60.

    PubMed  CAS  Google Scholar 

  2. Gold K & Rabins PV (1989) Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases. Compr Psychiatry 30:90–98.

    Article  PubMed  CAS  Google Scholar 

  3. Hori H et al. (2000) Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharm 15:117–119.

    Article  CAS  Google Scholar 

  4. Batra A et al. (1997) Therapeutic options in Charles Bonnet syndrome. Acta Psychiatr Scand 96:129–133.

    PubMed  CAS  Google Scholar 

  5. Terao T (1998). Effect of Carbamazepine and clonazepam combination on Charles Bonnet syndrome: a case report. Hum Psychopharmacol Clin Exp 13:451–453.

    Google Scholar 

Literatur

  1. Massey EW (1998) Sensory mononeuropathies. Semin Neurol 18: 177–183.

    PubMed  CAS  Google Scholar 

  2. Mumenthaler M, Schliack H (1987) Läsionen peripherer Nerven. Thieme, Stuttgart New York.

    Google Scholar 

Literatur

  1. Pelota H (1999) Prophylaxis of bacterial meningitis. Infectious Disease Clinics of North America, 3:658–710.

    Google Scholar 

Literatur

  1. Harsh GR, Smith AR, Loeffler JS (2000). Proton Beam Therapy. In: Bernstein M, Burger MS (Hrsg.) Neuro-Oncology. The Essentials. Thieme, New York.

    Google Scholar 

Literatur

  1. Winkler D (1998). Tumoren der Pinealis. In: Schlegel U, Westphal M. Neuroonkologie. Thieme, Stuttgart New York.

    Google Scholar 

  2. Kreth FW, Bise K (2001). Tumoren der Pinealisregion. In: Tumorzentrum München (Hrsg.) Hirntumoren und primäre Tumoren des Rückenmarks. Zuckschwerdt, München.

    Google Scholar 

  3. Herrmann H-D, Westphal M, Winkler K et al. (1994) Treatment of non-germinomatous germcell tumors in the pineal region. Neurosurgery 34:524–529.

    PubMed  CAS  Google Scholar 

Literatur

  1. Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum. 1990; 33(8):1068–1073.

    PubMed  CAS  Google Scholar 

  2. Gayraud M, et al. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: Comparison of steroids and oral or pulse cyclophosphamide in 25 patients. Br J Rheumatol 1997; 36:1290–1297.

    Article  PubMed  CAS  Google Scholar 

  3. Cohen P, et al. Persistance of ANCA in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 1995; 13:193–198.

    PubMed  CAS  Google Scholar 

  4. Gross WL. Churg-Strauss syndrome: update on recent developments. Curr Opin Rheumatol; 2002; 14:11.14.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Crawshaw C, Frazer AM, Merriam WF, Mulholland RC, Webb JK (1984) A comparison of surgery and chemonucleolysis in the treatment of sciatica. A prospective randomized trial. Spine 9:195–198

    PubMed  CAS  Google Scholar 

  2. Dabezies EJ, Langford K, Morris J, Shields CB, Wilkinson HA (1988) Safety and efficacy of chymopapain (Discase) in the treatment of sciatica due to a herniated nucleus pulposus. Results of a randomized, double-blind study. Spine 13:561–565

    PubMed  CAS  Google Scholar 

  3. Fraser RD (1984) Chymopapain for the treatment of intervertebral disc herniation. The final report of a double-blind study. Spine 9:815–818

    PubMed  CAS  Google Scholar 

  4. Javid MJ, Nordby EJ, Ford LT, Hejna WJ, Whisler WW, Burton C, Millett DK, Wiltse LL, Widell EH Jr, Boyd RJ, Newton SE, Thisted R (1983) Safety and efficacy of chymopapain (Chymodiactin) in herniated nucleus pulposus with sciatica. Results of a randomized, double-blind study. JAMA 249:2.489–2.494

    Article  Google Scholar 

  5. Maroon JC, Abla A (1985) Microdiscectomy versus chemonucleolysis. Neurosurgery 16:644–649

    PubMed  CAS  Google Scholar 

  6. Schenk KD, Freischütz G (1986) [Clinical evaluation of Chymodiactin and post-marketing surveillance]. Neurochirurgia 29:167–172

    PubMed  Google Scholar 

  7. Shields CB, Reiss SJ, Garretson HD (1987) Chemonucleolysis with chymopapain: results in 150 patients. J Neurosurg 67:187–191

    PubMed  CAS  Google Scholar 

Literatur

  1. ISUIA Investigators (1998). Unruptured intracranial aneurysms — risk of rupture and risks of surgical intervention, The New England Journal of Medicine 24: 1725–1733.

    Google Scholar 

Literatur

  1. Alvir et al. (1993) Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 329:162–7.

    Article  PubMed  CAS  Google Scholar 

  2. Atkin et al. (1996) Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 169:483–8.

    PubMed  CAS  Google Scholar 

  3. Bonuccelli et al. (1997) Clozapine in Parkinson’s disease tremor. Effects of acute and chronic administration. Neurology 49:1587–90.

    PubMed  CAS  Google Scholar 

  4. The Parkinson Study Group (1999). Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. N Engl J Med 340:757–63.

    Article  Google Scholar 

Literatur

  1. Bolton CF, Gilbert JJ, Hahn AF (1984) Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 47: 1223–1231.

    Article  PubMed  CAS  Google Scholar 

  2. Gutmann L, Hopf HC (1998) Critical-Illness-Neuropathie und-Myopathie. Akt. Neurologie 25: 337–340.

    Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Klinik für Neurologie mit Klinischer Neurophysiologie, Alfried-Krupp-Krankenhaus, Alfried-Krupp-Straße 21, 45131, Essen

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). C. In: Berlit, P. (eds) Therapielexikon Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26367-5_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-26367-5_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67137-4

  • Online ISBN: 978-3-540-26367-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation